换一批
换一批Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
作者：
主题词
成年人(Adult);抗体, 单克隆(Antibodies, Monoclonal);抗体, 肿瘤(Antibodies, Neoplasm);抗肿瘤药(Antineoplastic Agents);环孢菌素(Cyclosporine);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);霍奇金病(Hodgkin Disease);人类(Humans);淋巴细胞去除术(Lymphocyte Depletion);淋巴细胞输注(Lymphocyte Transfusion);男(雄)性(Male);美法仑(Melphalan);甲氨蝶呤(Methotrexate);中年人(Middle Aged);多元分析(Multivariate Analysis);骨髓摘除激动剂(Myeloablative Agonists);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);阿糖腺苷(Vidarabine)
DOI
10.1111/j.1365-2141.2007.06759.x
PMID
17854309
发布时间
2017-11-16
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
